Testing an Ebola vaccine with a COVID-19 booster
Part of Infections, Lungs & breathing clinical trials.
This study tests whether it is safe and effective to give an Ebola vaccine at the same time as a COVID-19 booster shot. It may help find a way to protect against both diseases with fewer clinic visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have already completed an initial COVID-19 vaccination series (any WHO-approved vaccine).
- You have never had an Ebola vaccine or been exposed to Ebola virus.
- You are not currently pregnant or breastfeeding, and can avoid close contact with vulnerable people and farm animals for 6 weeks after vaccination.
- You do not have a weakened immune system, have not used immunosuppressive medications in the last 6 months, and have not had cancer (other than non-melanoma skin cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a booster dose of one of two Ebola vaccines (Ervebo® or Zabdeno®) is safe and works well in people who already got an Ebola vaccine more than 4 months ago. It's especially for people living in the Democratic Republic of Congo (DRC) who may have been vaccinated before and might need a stronger, longer-lasting immune response.
This Phase 2 study compares Ebola vaccine immune responses when one Ebola treatment (Inmazeb) is given, then a vaccine (Ervebo) is given later. The goal is to see how the delay in timing changes your body’s immune response.
This trial tests a new type of COVID-19 booster vaccine that targets a protein to help your immune system. It's for people who already had a primary vaccine series and at least one mRNA booster, with the last booster at least 6 months ago.
This Phase 3 trial tests a booster vaccine made from a three-part COVID-19 protein (aimed at XBB, BA.5, and Delta) to see how well it works and is tolerated. It may help adults who are due for a COVID-19 booster, including people with certain health conditions, depending on screening results.
This Phase 2 study tests a booster vaccine made from a COVID-19 protein (XBB + prototype) to help your immune system respond better. You may be able to join if you’re an adult who is due for a booster and meets health and safety screening checks.
This trial tests a new COVID-19 vaccine called VYD2311, alone or with another COVID-19 vaccine, in healthy adults. The goal is to see if it is safe and helps your body fight the virus.
Hear when a new Ebola Virus Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.